DK0680346T3 - Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod - Google Patents

Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod

Info

Publication number
DK0680346T3
DK0680346T3 DK93904180T DK93904180T DK0680346T3 DK 0680346 T3 DK0680346 T3 DK 0680346T3 DK 93904180 T DK93904180 T DK 93904180T DK 93904180 T DK93904180 T DK 93904180T DK 0680346 T3 DK0680346 T3 DK 0680346T3
Authority
DK
Denmark
Prior art keywords
blood
nitric oxide
oxide concentration
increasing
increasing nitric
Prior art date
Application number
DK93904180T
Other languages
English (en)
Inventor
Anthony E Bolton
Original Assignee
Vasogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Inc filed Critical Vasogen Inc
Application granted granted Critical
Publication of DK0680346T3 publication Critical patent/DK0680346T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
DK93904180T 1992-02-07 1993-02-08 Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod DK0680346T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83279892A 1992-02-07 1992-02-07
US94132692A 1992-09-04 1992-09-04
PCT/GB1993/000259 WO1993015779A1 (en) 1992-02-07 1993-02-08 Method of increasing the concentration of nitric oxide in blood

Publications (1)

Publication Number Publication Date
DK0680346T3 true DK0680346T3 (da) 2002-10-28

Family

ID=27125561

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02014086T DK1243278T3 (da) 1992-02-07 1993-02-08 Anvendelse af blod, som har en foröget koncentration af nitrogenoxid, til fremstilling af et medikament
DK93904180T DK0680346T3 (da) 1992-02-07 1993-02-08 Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02014086T DK1243278T3 (da) 1992-02-07 1993-02-08 Anvendelse af blod, som har en foröget koncentration af nitrogenoxid, til fremstilling af et medikament

Country Status (13)

Country Link
US (1) US5834030A (da)
EP (2) EP0680346B1 (da)
JP (1) JP3989949B2 (da)
AT (2) ATE350046T1 (da)
AU (1) AU681999B2 (da)
CA (1) CA2129630C (da)
DE (2) DE69332087T2 (da)
DK (2) DK1243278T3 (da)
ES (2) ES2280454T3 (da)
HK (1) HK1053068B (da)
NZ (1) NZ249176A (da)
PT (2) PT1243278E (da)
WO (1) WO1993015779A1 (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
NZ306395A (en) * 1995-05-05 2000-02-28 Vasogen Inc Treatment of blood to remove symptoms of vascular disorders by elevation of temperature, ultraviolet radiation or treatment with an oxidative environment
AU760465B2 (en) * 1995-05-05 2003-05-15 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US6866755B2 (en) * 2001-08-01 2005-03-15 Battelle Memorial Institute Photolytic artificial lung
CA2206180A1 (en) * 1997-05-27 1998-11-27 Vasogen Inc. Treatment of chronic post-traumatic pain syndromes
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
PT1011696E (pt) * 1997-09-12 2004-03-31 Vasogen Ireland Ltd Tratamento do stresse e precondicoes contra o stresse
JPH11217330A (ja) 1998-01-30 1999-08-10 Sumitomo Pharmaceut Co Ltd 神経栄養因子分泌促進剤
US6264646B1 (en) 1998-11-13 2001-07-24 Vasogen Ireland Limited Method for preventing and reversing atherosclerosis in mammals
US7045124B1 (en) * 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
NZ512849A (en) * 1999-01-12 2003-02-28 Ct De Rech Du Ct Hospitalier D Pre-conditioning against cell death
US6589759B1 (en) 1999-03-30 2003-07-08 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
CA2271190A1 (en) * 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
AU776660B2 (en) * 1999-09-16 2004-09-16 Vasogen Ireland Limited Apparatus and process for conditioning mammalian blood
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
CA2309424A1 (en) 2000-05-25 2001-11-25 Vasogen Ireland Limited Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
AP1682A (en) 2000-08-11 2006-11-27 David R Whitlock Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same.
NL1015999C2 (nl) * 2000-08-23 2002-02-26 A J Van Liebergen Holding B V Inrichting voor het verwarmen van bloed of andere fysiologische vloeistoffen.
CA2327630A1 (en) * 2000-12-05 2002-06-05 Vasogen Ireland Limited Transforming growth factor regulation
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
CA2433803A1 (en) * 2001-01-16 2002-07-25 Mark E. Meyerhoff Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7122208B2 (en) 2001-04-06 2006-10-17 Vasogen Ireland Limited Compositions containing apoptotic entities
WO2003011359A2 (en) * 2001-08-01 2003-02-13 Monzyk Bruce F Artificial pulmonary capillary
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
US20050244382A9 (en) * 2002-01-11 2005-11-03 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
WO2003086503A2 (en) * 2002-04-10 2003-10-23 Vasogen Ireland Limited Electrocardiographic aspects of chf treatment
US7531133B2 (en) 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20050087498A1 (en) * 2003-07-31 2005-04-28 Keyser Steven A. Ozone delivery system including gas-fluid contacting devices and methods of use
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
WO2005030147A2 (en) * 2003-09-26 2005-04-07 Whitlock David R Methods of using ammonia oxidizing bacteria
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
US8518457B2 (en) 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
MXPA06013111A (es) 2004-05-11 2007-05-23 Sensormedics Corp Dosificacion intermitente de gas de oxido nitrico.
EP1773360A4 (en) * 2004-07-20 2009-09-02 Vasogen Ireland Ltd TREATMENT OF ACUTE INFLAMMATORY EVENTS
CN100420490C (zh) * 2005-04-13 2008-09-24 刘余厚 全自动紫外线照射充氧自血回输处理方法及设备
WO2007005758A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Methods , compositions and devices for promoting angiogenesis
CN101378792A (zh) * 2005-12-02 2009-03-04 密执安大学评议会 聚合物组合物、涂层和装置及其制备和使用方法
US8079998B2 (en) 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
US20080181832A1 (en) * 2007-01-30 2008-07-31 Lih-Ren Shiue Pocket-size ozone generator
CA2902061C (en) * 2013-02-28 2023-08-08 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
CN106456678A (zh) 2014-04-15 2017-02-22 Ao生物医学有限责任公司 氨氧化型亚硝化单胞菌菌株d23
KR20170002568A (ko) * 2014-05-09 2017-01-06 땡스템 에스알엘 전혈로부터의 성체 줄기세포 증대 방법
SE541036C2 (en) 2014-09-15 2019-03-12 Sangair Ab Apparatus and system for ozonating blood, and method for ozonating blood prior to storage
WO2022119900A1 (en) * 2020-12-01 2022-06-09 Boston Scientific Scimed, Inc. Intravascular ultraviolet catheter and methods for making and using the same
EP4295872A1 (en) * 2022-06-22 2023-12-27 Purotech S.r.l. Blood treatment apparatus
IT202300002148A1 (it) * 2023-02-08 2024-08-08 Purotech S R L Apparato per il trattamento ematico.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US695647A (en) * 1901-10-30 1902-03-18 James Harold Warner Combination-tile for floors.
DE1068428C2 (de) * 1957-05-21 1960-04-21 Hermann Dr Med Jentjens Verfahren und Einrichtung zur Herstellung von oxygeniertrm Blut
US3325641A (en) * 1964-02-17 1967-06-13 George W Jones Apparatus for treating a thin film of liquid by exposure to radiant energy
US3715430A (en) * 1969-08-04 1973-02-06 E Ryan Purified oxygen gas containing ozone and higher oxygen polymers
DE2926523A1 (de) * 1979-06-30 1981-01-22 Margit Stadtlaender Geraet zur therapeutischen behandlung von blut und anderen koerpereigenen wie auch koerperfremden fluessigkeiten, substanzen und gasen zum zweck der therapeutischen wie auch diagnostischen anwendung in der human- wie auch veterinaermedinzin usw.
JPS58198466A (ja) * 1982-05-12 1983-11-18 Teijin Ltd ５−チアプロスタグランジン類およびその製造法
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE8704467U1 (de) * 1987-01-15 1988-05-26 Quarzlampenfabrik Dr.-Ing. Felix W. Müller GmbH & Co KG, 45239 Essen Gerät zur Herstellung von oxygeniertem Blut
CA1316666C (en) * 1987-10-22 1993-04-27 Robert E. Duthie, Jr. Sterilization method and apparatus
ATE120375T1 (de) * 1988-04-29 1995-04-15 Medizone Int Inc Vorrichtung für die gesteuerte generierung und verabreichung von ozon.
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human

Also Published As

Publication number Publication date
HK1053068A1 (en) 2003-10-10
EP0680346B1 (en) 2002-07-03
WO1993015779A1 (en) 1993-08-19
DE69332087D1 (de) 2002-08-08
ATE350046T1 (de) 2007-01-15
CA2129630A1 (en) 1993-08-08
EP1243278B1 (en) 2007-01-03
JPH07503722A (ja) 1995-04-20
EP0680346A1 (en) 1995-11-08
DK1243278T3 (da) 2007-05-07
ES2280454T3 (es) 2007-09-16
HK1053068B (en) 2007-03-30
CA2129630C (en) 2003-09-23
AU3506393A (en) 1993-09-03
JP3989949B2 (ja) 2007-10-10
ES2179828T3 (es) 2003-02-01
PT680346E (pt) 2002-10-31
ATE219953T1 (de) 2002-07-15
US5834030A (en) 1998-11-10
DE69334101T2 (de) 2007-10-04
EP1243278A3 (en) 2003-02-26
NZ249176A (en) 1996-11-26
PT1243278E (pt) 2007-04-30
AU681999B2 (en) 1997-09-18
DE69332087T2 (de) 2002-10-24
EP1243278A2 (en) 2002-09-25
DE69334101D1 (de) 2007-02-15

Similar Documents

Publication Publication Date Title
PT680346E (pt) Metodo para aumentar a concentracao de oxido nitrico no sangue
DE10299002I1 (de) Verwendung von No zur Behandlung oder Praevention der Bronchokonstriktion
DE69102695D1 (de) Behandlung von verunreinigten abwässern und bodenwässern.
DK0387867T3 (da) Præparat indeholdende D-cycloserin og D-alanin til forbedring af hukommelse og indlæringsevne eller til behandling af en kognitiv eller psykotisk lidelse
NO20005800D0 (no) Fremgangsmåte og apparat for inaktivering av forurensninger i biologisk fluid
ATE67092T1 (de) Verwendung von chlordioxidgas als chemisches sterilisierungsmittel.
BR9104988A (pt) Processo de determinacao da concentracao de um agente de tratamento adicionado a um corpo circulacao de agua,e,processo de determinacao do consumo de um agente de tratamento
SE8802781L (sv) Foerfarande foer avfuktning av gaser
NO944456L (no) Behandling av inkontinens
DE69432279D1 (de) Methode und Katalysator zur Behandlung von Dioxinen enthaltenden Rauchgasen
DE59103000D1 (de) Anordnung zur Gasbehandlung von verunreinigtem Erdreich.
SE9302478D0 (sv) Gasblandning och apparat foer att tillfoera gasblandningen till lungorna hos ett levande vaesen
DK0615751T3 (da) Anvendelse af tachykininantagonister til behandling af emesis
ES2032548T3 (es) Un metodo de tratamiento de sistemas acuosos o no acuosos mediante un agente de control microbiologico. (reserva del art. 167.2 cpe).
DE69613058D1 (de) Vorbeugung und Behandlung von topischen viralen Infektionen mit Perfluoropolyäthern oder deren Zusammensetzungen
ES2024646B3 (es) Eliminador de oxigeno para agua de calderas y metodo de empleo
DE69308879D1 (de) Methode zur behandlung von abfallverbrennungsrückständen und deren verwendung als adsorptionsmittel
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
ES2085059T3 (es) Procedimiento para tratar gas de chimenea.
NO962580D0 (no) Metallimplantat og fremgangsmåte for behandling av et metallimplantat
ATE176175T1 (de) Verfahren zur behandlung von schwefeldioxid enthaltenden gasen
DE58900998D1 (de) Verfahren zur entgiftung eines durch chromat belasteten bodens.
SE9301606D0 (sv) Composition for the treatment of impaired hair growth
ATE126094T1 (de) Behandlung von abgas.
ATE26411T1 (de) Verfahren fuer die reduzierung des so2- und/oder nox-gehaltes in rauchgas.